MAPT and Alzheimer disease: The activation of FYN can lead to the accumulation of Aβ plaques in the brains of AD patients, abnormal phosphorylation of Tau protein, and neuronal damage, resulting in a gradual decline in cognitive function and memory (Meur and Karati, 2025).